MMP9 and glioblastoma: Moreover, low-expression of MMP9 was a favorable prognostic factor for primary glioblastoma, and it was thought that the glioblastoma with MMP9 low-expression would benefit more from radiotherapy combined with TMZ chemotherapy than radiotherapy alone [30].